SciELO - Scientific Electronic Library Online

 
vol.25 número1Efficacy of Lutetium-177 DOTATATE/TOC in Advanced Neuroendocrine TumorsVideo endoscopic inguinal lymphadenectomy (VEIL) for the management of vulvar cancer at the Instituto Nacional de Cancerología (Bogotá, Colombia) índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista Colombiana de Cancerología

versão impressa ISSN 0123-9015

Resumo

PUPO-BALBOA, Judith Beatriz et al. DNA damage as a potential marker in the clinical follow-up of female patients with treated cancer. rev.colomb.cancerol. [online]. 2021, vol.25, n.1, pp.25-42.  Epub 08-Ago-2021. ISSN 0123-9015.  https://doi.org/10.35509/01239015.122.

Objective:

To identify individual differences in the basal damage (DB) of peripheral leukocyte DNA from women with cancer in remission.

Methods:

Cross-sectional analytical study in which 24 women with cancer in remission from different locations and 24 supposedly healthy women participated. The alkaline comet assay and the neutral variant were used to determine single-stranded breaks (DB-A), and double-stranded DNA breaks (DB-N), respectively.

Results:

Although there were no differences between the mean values of DNA damage in patients and controls (DB-N: p = 0.43 and DB-A: p = 0.13), 41.6% of the patients presented an increase of one type or another of DNA breaks, with respect to the corresponding cut-off points of the control women. DB-N was correlated with increasing age (r2 = 0.1833; r = 0.4281; p = 0.036) in the patients. DB-A was elevated in those who had received anticancer combination therapy (p = 0.024) and in those who were undergoing treatment with tamoxifen (p = 0.033); while it was decreased in those that consumed antioxidants (p = 0.006) and in those that combined tamoxifen and antioxidants (p = 0.020).

Conclusions:

Individual differences were identified in both types of DNA strand breaks that are of medical interest in the studied patients. Baseline DNA damage determined by comet assay is a potential tool in the clinical follow-up of cancer patients in remission.

Palavras-chave : Cancer; alkaline comet assay; neutral comet assay; DNA damage.

        · resumo em Espanhol     · texto em Inglês     · Inglês ( pdf )